Data / Drug companies / Chunghwa Chemical Synthesis & Biotech. Ltd
Chunghwa Chemical Synthesis & Biotech. Ltd: 48 products in the FDA NDC directory, labeler code 52076
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Chunghwa Chemical Synthesis & Biotech. Ltd (labeler code 52076) lists 48 products in the FDA National Drug Code Directory. By type: 48 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on March 26, 2026.
The request: Watch Chunghwa Chemical Synthesis & Biotech. Ltd (FDA labeler code 52076): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52076
- Products in commercial distribution
- 48
- Packages
- 83
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule V 1
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- January 1, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 48 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 48 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 44 | 91.7% |
| Crystal | 2 | 4.2% |
| Injection, solution | 1 | 2.1% |
| Oil | 1 | 2.1% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Tenapanor hydrochloride | 52076-6284 | Powder | Bulk ingredients | March 26, 2026 |
| Semaglutide | 52076-6282 | Powder | Bulk ingredients | August 19, 2024 |
| Ozanimod | 52076-6281 | Powder | Bulk ingredients | May 16, 2024 |
| Trilaciclib dihydrochloride | 52076-6280 | Powder | Bulk ingredients | March 18, 2024 |
| Dalbavancin hydrochloride | 52076-6279 | Powder | Bulk ingredients | September 18, 2023 |
| Selumetinib sulfate | 52076-6278 | Powder | Bulk ingredients | July 10, 2023 |
| Ruxolitinib free base | 52076-6277 | Powder | Bulk ingredients | April 11, 2023 |
| Ruxolitinib phosphate | 52076-6276 | Powder | Bulk ingredients | October 27, 2022 |
| Trilaciclib dihydrochloride | 52076-6275 | Powder | Bulk ingredients | October 26, 2022 |
| Eltrombopag olamine | 52076-6274 | Powder | Bulk ingredients | October 18, 2022 |
| Difelikefalin acetate | 52076-6273 | Powder | Bulk ingredients | December 14, 2021 |
| Setmelanotide acetate | 52076-6271 | Powder | Bulk ingredients | August 31, 2021 |
| Lanreotide acetate | 52076-6272 | Powder | Bulk ingredients | August 1, 2021 |
| Everolimus b02 | 52076-6270 | Powder | Bulk ingredients | February 2, 2021 |
| Eslicarbazepine acetate | 52076-6269 | Powder | Bulk ingredients | February 1, 2021 |
| Brivaracetam | 52076-6268 | Powder | Bulk ingredients | December 11, 2020 |
| Ozanimod hydrochloride | 52076-6266 | Powder | Bulk ingredients | December 11, 2020 |
| Tofacitinib citrate | 52076-6267 | Powder | Bulk ingredients | December 8, 2020 |
| Favipiravir | 52076-6265 | Powder | Bulk ingredients | September 3, 2020 |
| Mycophenolate sodium | 52076-6236 | Powder | Bulk ingredients | March 26, 2020 |
| Lanreotide acetate | 52076-6264 | Powder | Bulk ingredients | October 1, 2019 |
| Palbociclib | 52076-6263 | Crystal | Bulk ingredients | May 29, 2019 |
| Midostaurin | 52076-6262 | Powder | Bulk ingredients | May 28, 2019 |
| Caspofungin acetate | 52076-6230 | Powder | Bulk ingredients | November 1, 2018 |
| Ribociclib free base | 52076-6261 | Powder | Bulk ingredients | October 3, 2018 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.